Stryker Corp
NYSE:SYK
Relative Value
The Relative Value of one SYK stock under the Base Case scenario is 352.7 USD. Compared to the current market price of 335.61 USD, Stryker Corp is Undervalued by 5%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
SYK Competitors Multiples
Stryker Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | ||
IE |
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.7 | 38.9 | 18.6 | 31.4 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
366.6B CNY | 10.6 | 32.2 | 28.1 | 28.1 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 | ||
US |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.5B USD | 11.3 | 49.1 | 34.5 | 38.1 |